MO

Moogene Medi Co., Ltd.

Develops LNP drug delivery systems for severe diseases, offering R&D to GMP manufacturing support.

322970 | KO

Overview

Corporate Details

ISIN(s):
KR7322970005
LEI:
Country:
South Korea
Address:
경기도 하남시 미사강변중앙로7번안길 25씨동 10층(풍산동,유-테크밸리씨타워), 하남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Moogene Medi Co., Ltd. is a biotechnology company specializing in nano-medicine and the development of advanced drug delivery systems. The company focuses on its Lipid Nanoparticle (LNP) carrier system platform to create safer and more effective methods for transporting various therapeutic agents, such as genes, chemicals, and proteins. Moogene Medi aims to address incurable and severe diseases by developing novel therapeutics based on optimized LNPs tailored to each drug's characteristics. The company provides end-to-end support, from research and development to clinical study manufacturing in its aseptic, GMP-grade facility, also offering assay services for its developed nano-carrier systems.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-18 00:00
Regulatory News Service
임상시험단계진입ㆍ종료(자율공시)
Korean 8.9 KB
2025-06-30 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2025-06-13 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-03-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 14.7 KB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 9.9 KB
2025-03-19 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 277.8 KB
2025-03-12 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 83.0 KB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 91.4 KB
2025-03-04 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 7.0 KB
2025-03-04 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.4 KB
2025-01-06 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.4 KB
2024-12-13 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.2 KB
2024-11-25 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2024-11-11 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2024-10-02 00:00
Regulatory News Service
기타주요경영사항(자율공시)
Korean 6.9 KB

Automate Your Workflow. Get a real-time feed of all Moogene Medi Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Moogene Medi Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Moogene Medi Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America
APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea
397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.